Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Aussie, rand flounder as Omicron spooks investors

Published 12/01/2021, 08:06 PM
Updated 12/01/2021, 08:12 PM
© Reuters. FILE PHOTO: Australian dollars are seen in an illustration photo February 8, 2018. REUTERS/Daniel Munoz

By Kevin Buckland

(Reuters) - The safe-haven yen hovered near a seven-week high on Thursday while the rand and riskier currencies languished as the Omicron coronavirus variant established itself as the dominant strain in South Africa and continued to spread globally.

Early indications suggesting Omicron may be markedly more contagious than previous variants have rattled financial markets on worries that a return to travel bans and lockdowns could choke off the nascent global recovery.

The strain has been found in places as widespread as Australia, Britain, Canada and Japan, even as those countries rapidly tighten their borders.

Against Japan's currency, the U.S. dollar edged 0.11% higher to 112.875 yen, but remained close to Tuesday's low of 112.535, a level not seen since Oct. 11.

Against the South African rand, the greenback was off 0.12% at 16.0025, after a more than 1% surge overnight.

The number of new cases reported in South Africa - where Omicron was first discovered four weeks ago - doubled from Tuesday to Wednesday. The country's National Institute for Communicable Diseases said 74% of all the virus genomes it had sequenced last month had been of the new variant.

The first case in the United States, reported on Wednesday, was a fully vaccinated person in California who returned from South Africa on Nov. 22 and tested positive seven days later.

Despite the uncertainty spawned by Omicron, Federal Reserve Chair Jerome Powell reiterated in Day 2 of testimony to Congress on Wednesday that he and fellow policymakers will consider at their Dec. 14-15 meeting a faster taper of stimulus, which could open the door to earlier interest rates hikes.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"If nothing else, (Powell's repeat testimony) tells you he is not in the least unhappy about how markets have interpreted what he said earlier," Ray Attrill, head of FX strategy at National Australia Bank (OTC:NABZY), wrote in a note to clients.

"The truth is we are less than a week into the 2-3 week timeframe that anyone worth listening to - epidemiologists, not market analysts - say is necessary before an informed judgement can be made with respect both to the seriousness of this COVID-19 variant and the efficacy of existing vaccines."

The dollar index, which measures the currency versus six peers, edged 0.03% higher to 96.07, consolidating in the middle of its range over the past two weeks, when it also rose as high as 96.938 for the first time since July of last year.

The risk-sensitive Aussie was about flat at $0.7105, not far from Tuesday's low of $0.7063, its weakest since early November of last year.

Sterling, often considered a risk-on currency, was little changed at $1.3276. It plunged to a near one-year low of $1.31945 on Tuesday.

The euro was steady at $1.1316, continuing its recovery after dipping to a near 17-month low of $1.1186 last month.

Latest comments

Whatever Powell says, do the OPPOSITE. Powell says: we will continue to taper. Reality: FED increases taper.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.